Cannell & Spears’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Sell |
26,461
-38,065
| -59% | -$20M | 0.28% | 86 |
|
|
2025
Q1 | $40.9M | Buy |
64,526
+48,471
| +302% | +$30.7M | 0.88% | 34 |
|
|
2024
Q4 | $11.4M | Buy |
16,055
+5,415
| +51% | +$3.86M | 0.23% | 91 |
|
|
2024
Q3 | $11.2M | Buy |
10,640
+78
| +0.7% | +$82K | 0.22% | 96 |
|
|
2024
Q2 | $11.1M | Sell |
10,562
-277
| -3% | -$291K | 0.23% | 90 |
|
|
2024
Q1 | $10.4M | Buy |
+10,839
| New | +$10.4M | 0.22% | 98 |
|